Cart
sales@molnova.com
Magrolimab
CAS No. 2169232-81-7
Magrolimab( —— )
Catalog No. M34758 CAS No. 2169232-81-7
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 287 | Get Quote |
|
| 5MG | 549 | Get Quote |
|
| 10MG | 803 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMagrolimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionMagrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
-
DescriptionMagrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2169232-81-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Caner Saygin, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul;48:100791.?
molnova catalog
related products
-
GALANGIN-3-METHYLETH...
GALANGIN-3-METHYLETHER has antibacterial activity it has inhibitory effects on Pseudomonas aeruginosa.?GALANGIN-3-METHYLETHER has hypolipidemic activity the action is due to the inhibition of pancreatic lipase.
-
Progabide
Progabide is an agonist of the gamma-aminobutyric acid receptor.
-
TG2-IN-3h
TG2-IN-3h is a transglutaminase (TGase) inhibitor used in the study of neurological and immune system disorders.
